Literature DB >> 6581546

Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.

C M Balch, A B Tilden, P A Dougherty, G A Cloud, T Abo.   

Abstract

p6e monoclonal antibody HNK-1 reacts exclusively with human granular lymphocytes that comprise 16 +/- 1.4% of blood mononuclear cells. In normal individuals, almost all natural killer (NK) and killer (K) cell function resides in this lymphocyte subset. The level of HNK-1+ granular lymphocytes, their stage of differentiation, and NK cell function were examined in 70 colon cancer patients and the results compared with data for 114 age-matched normal individuals. Median levels of granular lymphocytes were significantly depressed in colon cancer patients compared to controls (9% versus 16.5%, P less than 0.0001). Despite the depressed numbers of circulating HNK-1+ cells, NK cell function in the colon cancer patients was essentially the same as in normals (P = 0.78). The HNK-1+ lymphocyte level correlated exactly with NK cell function in about two thirds of normal individuals but only one third of colon cancer patients (P = 0.025). Three possible mechanisms for this dichotomy were examined. First, lymphoid cell subpopulations purified with a fluorescence-activated cell sorter (FACS) were examined for altered NK cell functional activity. HNK-1+ cells from the colon cancer patients exhibited significantly less NK functional activity compared to normals (796 versus 1046 lytic units, P = 0.04). Interestingly, the HNK-1- fraction (predominantly T lymphocytes) had increased NK cell functional activity in the colon cancer patients compared to normals (373 versus 218 lytic units, P = 0.0001). Purified monocytes did not contribute to NK cell functional activity. Second, the functional maturity of the HNK-1+ lymphocytes was correlated with NK activity. Two subsets of HNK-1+ cells were identified by surface membrane markers and purified with the FACS. The more mature HNK-1+ subset (i.e., HNK+Leu-4-M1+) exhibited almost ten times more NK cell functional activity than did the less mature cell fraction (i.e., HNK+Leu-4+M1-) cells in normal individuals (2230 versus 286 lytic units/10(7) cells). Further analysis demonstrated that the ratio of mature to immature HNK+ cells in normal individuals was 3:1, while it was decreased to a 1:1 ratio in colon cancer patients P = 0.005). Third, the influence of prostaglandin-mediated suppression on NK cell activity was examined. PGE2 did not appear to influence NK cell function, since NK cell function was unchanged in vitro in the presence of a prostaglandin synthesis inhibitor.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6581546

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.

Authors:  K Eckert; E Grünberg; P Immenschuh; F Garbin; E D Kreuser; H R Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological data.

Authors:  M N Saleh; A F LoBuglio; R H Wheeler; K J Rogers; A Haynes; J Y Lee; M B Khazaeli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Definite spontaneous cell-mediated cytotoxicity and HNK-1 cells in the human large intestine.

Authors:  M Chiba; H Ohta; O Masamune; Y Yoshida
Journal:  Gastroenterol Jpn       Date:  1986-12

4.  Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.

Authors:  H O Klein; G Golbach; P Voigt; C Coerper; C Bernhardt
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer.

Authors:  J R Monson; C W Ramsden; G R Giles; T G Brennan; P J Guillou
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

6.  Impaired local natural killer cell activity in human colorectal carcinomas.

Authors:  N M Aparicio-Pagés; H W Verspaget; S A Peña; C B Lamers
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.

Authors:  Masahiro Ohira; Ryuichi Hotta; Yuka Tanaka; Toshiharu Matsuura; Akin Tekin; Gennaro Selvaggi; Rodrigo Vianna; Camillo Ricordi; Phillip Ruiz; Seigo Nishida; Andreas G Tzakis; Hideki Ohdan
Journal:  Cancer Immunol Immunother       Date:  2021-07-19       Impact factor: 6.968

8.  Effect of a 12-week walking exercise program on body composition and immune cell count in patients with breast cancer who are undergoing chemotherapy.

Authors:  Ji Jeong Kim; Yun A Shin; Min Hwa Suk
Journal:  J Exerc Nutrition Biochem       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.